APA (7th ed.) Citation

Shan, M. (2026). Pre-Specified Safety Analysis of OS Data for Trials in Indolent or Early-Stage Cancers. Statistics in Biopharmaceutical Research, 18(2), 230. https://doi.org/10.1080/19466315.2025.2579553

Chicago Style (17th ed.) Citation

Shan, Minghua. "Pre-Specified Safety Analysis of OS Data for Trials in Indolent or Early-Stage Cancers." Statistics in Biopharmaceutical Research 18, no. 2 (2026): 230. https://doi.org/10.1080/19466315.2025.2579553.

MLA (9th ed.) Citation

Shan, Minghua. "Pre-Specified Safety Analysis of OS Data for Trials in Indolent or Early-Stage Cancers." Statistics in Biopharmaceutical Research, vol. 18, no. 2, 2026, p. 230, https://doi.org/10.1080/19466315.2025.2579553.